Partnerships

Begin with the question. Build the solution together.

KRI welcomes early discussion with researchers, hospitals, universities, biotechnology and pharmaceutical organisations, CROs, patient-focused networks and research consortia. Our teams help translate a scientific question into a realistic experimental, analytical and collaborative plan.

How KRI can contribute

Scientific co-development

Hypotheses, work packages, biomarker strategies, experimental plans and translational objectives.

Specialist infrastructure

Sequencing, automated NGS prep, molecular profiling, immunogenetics, high-dimensional cytometry, cell sorting, cytokine analysis and cryopreservation.

Integrated study design

Specimen strategy, method selection, controls, endpoints, analysis and interpretation shaped around the question.

Assay development

Design, optimisation and fit-for-purpose validation of approved panels and methods.

Translational research

TIL, ACT and CAR-T research; CRISPR screening; cell culture; mouse studies and PDX-associated work.

Consortium participation

Contribution to work packages, milestones, deliverables, risk planning, dissemination and outputs.

Population genomics

Research opportunities and population-aware context connected to the Cyprus Genome Project.

Quality-aware delivery

Transparent method status, specimen governance and project-specific quality planning.

Research topics

  • Cancer immunology & tumour microenvironment
  • Cellular therapies & immune modulation
  • Cancer genomics & precision diagnostics
  • Liquid biopsy, MRD, chimerism & longitudinal monitoring
  • Molecular pathology, clonal evolution & tumour heterogeneity
  • Immunogenetics, histocompatibility & transplantation immunology
  • Functional genomics, CRISPR screening & target discovery
  • Clinical-trial biomarkers, exploratory endpoints & multicentre research
  • Population genomics & the Cyprus Genome Project

Research-support pathway

  1. Step 01

    Scientific scoping

    Clarify the hypothesis, disease context, population, intervention, endpoint and decision to be supported.

  2. Step 02

    Feasibility

    Review cohort, specimens, volumes, timepoints, preanalytics, capacity, timelines and method readiness.

  3. Step 03

    Solution design

    Select or develop methods; define controls, sensitivity, analysis, reporting and integration.

  4. Step 04

    Qualification

    Document fitness for purpose, acceptance criteria, reproducibility and project-specific quality requirements.

  5. Step 05

    Study delivery

    Coordinate sample flow, testing, deviations, data review and milestone communication.

  6. Step 06

    Interpretation

    Integrate molecular, cellular, immunological, pathological and clinical information.

  7. Step 07

    Next-stage translation

    Identify validation, publication, consortium, diagnostic-development or therapeutic-research opportunities.

Discuss a study

Use the enquiry form for structured triage of research collaborations, consortium proposals, multicentre studies, facility discussions or fellowship visits. Please do not submit identifiable patient information, raw clinical records or sensitive datasets through this form.

Open the enquiry form →